Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more

TSX:MSCL - Post Discussion

Satellos Bioscience Inc > Post deleted SNOWFLAKES MANAGEMENT
View:
Post by Drambuey on Apr 24, 2024 3:10pm

Post deleted SNOWFLAKES MANAGEMENT

So you deleted my post did it hit too close to home SNOWFLAKE MANAGEMENT?  Let me get this straight you roll back the stock 20 to one collect $1.4 million in salaries and the stock is trading at $0.02 precondition ALL FACTS.  So you run to mommy because in this new world how dare you be held accountable for the pathetic job that your management team is doing, but hey who cares you all are still collecting money?
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities